These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26995367)

  • 21. Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry).
    Thind M; Holmes DN; Badri M; Pieper KS; Singh A; Blanco RG; Steinberg BA; Fonarow GC; Gersh BJ; Mahaffey KW; Peterson ED; Reiffel JA; Piccini JP; Kowey PR;
    Am J Cardiol; 2018 Nov; 122(10):1677-1683. PubMed ID: 30227964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Steinberg BA; Shrader P; Kim S; Thomas L; Fonarow GC; Ansell J; Kowey PR; Singer DE; Gersh BJ; Mahaffey KW; Peterson ED; Piccini JP;
    Am Heart J; 2016 Nov; 181():145-152. PubMed ID: 27823686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry.
    Piccini JP; Simon DN; Steinberg BA; Thomas L; Allen LA; Fonarow GC; Gersh B; Hylek E; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Spertus JA; Peterson ED;
    JAMA Cardiol; 2016 Jun; 1(3):282-91. PubMed ID: 27438106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Li YG; Miyazawa K; Wolff A; Zubaid M; Alsheikh-Ali AA; Sulaiman K; Lip GYH
    Int J Cardiol; 2019 Jan; 274():158-162. PubMed ID: 30291008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.
    Zhang H; Yang Y; Zhu J; Shao X; Liu Y; Zhao L; Yu P; Zhang H; He Q; Gu X
    Intern Med J; 2014 Aug; 44(8):742-8. PubMed ID: 24893684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study.
    Patel PJ; Katz R; Borovskiy Y; Killian A; Levine JM; McNaughton NW; Callans D; Supple G; Dixit S; Epstein AE; Marchlinski FE; Deo R
    Heart Rhythm; 2018 Apr; 15(4):487-493. PubMed ID: 29475795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) registry.
    Amerena J; Chen SA; Sriratanasathavorn C; Cho JG; Huang D; Omar R; Tse HF; King A
    Am J Cardiol; 2012 Feb; 109(3):378-82. PubMed ID: 22118827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between cancer and atrial fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study).
    O'Neal WT; Lakoski SG; Qureshi W; Judd SE; Howard G; Howard VJ; Cushman M; Soliman EZ
    Am J Cardiol; 2015 Apr; 115(8):1090-4. PubMed ID: 25711434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    O'Brien EC; Holmes DN; Ansell JE; Allen LA; Hylek E; Kowey PR; Gersh BJ; Fonarow GC; Koller CR; Ezekowitz MD; Mahaffey KW; Chang P; Peterson ED; Piccini JP; Singer DE
    Am Heart J; 2014 Apr; 167(4):601-609.e1. PubMed ID: 24655711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Simon D; Steinberg BA; Hong SJ; Kowey PR; Reiffel JA; Naccarelli GV; Chang P; Gersh BJ; Peterson ED; Piccini JP;
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    Echouffo-Tcheugui JB; Shrader P; Thomas L; Gersh BJ; Kowey PR; Mahaffey KW; Singer DE; Hylek EM; Go AS; Peterson ED; Piccini JP; Fonarow GC
    J Am Coll Cardiol; 2017 Sep; 70(11):1325-1335. PubMed ID: 28882229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.
    Bush D; Martin LW; Leman R; Chandler M; Haywood LJ;
    J Natl Med Assoc; 2006 Mar; 98(3):330-9. PubMed ID: 16573295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial Differences in Atrial Fibrillation Epidemiology, Management, and Outcomes.
    Nanda A; Kabra R
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(12):85. PubMed ID: 31820122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control.
    Gomez SE; Fazal M; Nunes JC; Shah S; Perino AC; Narayan SM; Tamirisa KP; Han JK; Rodriguez F; Baykaner T
    J Interv Card Electrophysiol; 2023 Aug; 66(5):1279-1290. PubMed ID: 36224481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Guan N; Zhu Z; Kowey PR; Allen LA; Fonarow GC; Hylek EM; Mahaffey KW; Freeman JV; Chang P; Holmes DN; Peterson ED; Piccini JP; Gersh BJ;
    Am Heart J; 2015 May; 169(5):647-654.e2. PubMed ID: 25965712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry.
    Melloni C; Shrader P; Carver J; Piccini JP; Thomas L; Fonarow GC; Ansell J; Gersh B; Go AS; Hylek E; Herling IM; Mahaffey KW; Yu AF; Peterson ED; Kowey PR;
    Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):192-197. PubMed ID: 28838088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.